A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
AstraZeneca’s experimental drug camizestrant significantly reduced the risk of disease progression or death in patients with advanced hormone receptor-positive, HER2-negative breast cancer by 56%, when prescribed based on early blood test results rather than visible tumor growth, experts announced Sunday at the American Society of Clinical Oncology (ASCO) meeting in Chicago.
The international trial marks a major shift in cancer treatment strategy by using liquid biopsy—a blood test that detects ESR1 gene mutations indicating early resistance to standard hormone therapies. Camizestrant, a selective estrogen receptor degrader (SERD), was shown to be effective in patients with early treatment resistance, even before tumors could be detected via imaging.
“This is going to be very impactful for our patients,” said Dr. Hope Rugo, head of breast medical oncology at City of Hope, California. “We’re staying ahead of the curve rather than reacting after the disease has already progressed,” added Dr. Eleonora Teplinsky, another ASCO expert.
The Phase 3 clinical trial involved 3,256 women, all previously treated with aromatase inhibitors and CDK4/6 inhibitors like Pfizer’s Ibrance or Novartis’ Kisqali. Among them, 315 women who developed ESR1 mutations were selected for a randomized trial. Those who switched to camizestrant plus CDK4/6 inhibitors experienced a median 16 months of progression-free survival compared to 9.2 months in the control group that continued standard therapy.
Camizestrant is not yet FDA-approved, but based on these findings, it may soon be adopted as part of a new treatment paradigm for early intervention in breast cancer progression.
AstraZeneca CEO Pascal Soriot acknowledged that integrating liquid biopsy into routine practice would initially be challenging but emphasized it as the future of cancer care.
In a separate announcement at the same ASCO meeting, another AstraZeneca drug, Imfinzi (durvalumab), showed promise in improving outcomes for early-stage stomach and esophageal cancer patients. When added to chemotherapy before and after surgery, Imfinzi reduced the risk of cancer recurrence, progression, or death by 29%.
Both sets of results were published in the New England Journal of Medicine and are expected to have lasting implications for the future of oncology.
United States prepares for the possibility of sustained, weeks-long military operations against Iran, two U.S. officials told Reuters as the images of...
The Somali Army carried out a targeted airstrike in southern Somalia, killing 15 al-Shabaab militants, the country’s Defence Ministry said on Sunday...
Israel’s cabinet on Sunday approved measures aimed at expanding state oversight of land in the occupied West Bank and facilitating land purchases by...
...
Iran is pursuing a nuclear agreement with the U.S. that delivers economic benefits for both sides, an Iranian diplomat was reported as saying on Sunda...
United States prepares for the possibility of sustained, weeks-long military operations against Iran, two U.S. officials told Reuters as the images of the USS Abraham Lincoln carrier strike group sailing and flying in formation were released on Sunday.
The Somali Army carried out a targeted airstrike in southern Somalia, killing 15 al-Shabaab militants, the country’s Defence Ministry said on Sunday.
Israel’s cabinet on Sunday approved measures aimed at expanding state oversight of land in the occupied West Bank and facilitating land purchases by settlers, a move Palestinian officials described as a 'de-facto annexation.'
U.S. President Donald Trump said on Sunday that member states of the newly formed Board of Peace will announce pledges exceeding $5 billion for Gaza’s reconstruction during a gathering in Washington this week.
U.S. Ambassador to NATO Matthew Whitaker said China has the power to bring an end to Russia’s war in Ukraine, arguing that Beijing is enabling Moscow’s military campaign.
American figure skating star Ilia Malinin endured a dramatic collapse in the men’s free skate on Friday night, falling twice and tumbling out of medal contention at the Milan Cortina Winter Olympics as Kazakhstan’s Mikhail Shaidorov surged to a surprise gold medal.
“Respected and feared globally,” U.S. President Donald Trump told troops at Fort Bragg on Friday (13 February), framing America’s renewed strength against to mounting pressure on Iran amid stalled nuclear talks.
Speaking at Munich Security Conference, Ukrainian foreign minister Andrii Sybiha calls for decisive steps ahead of expected Geneva talks
Thousands of fans packed River Plate’s Monumental Stadium in Buenos Aires on Friday for the first of three sold-out concerts by Puerto Rican reggaeton star Bad Bunny, as part of his “Debí Tirar Más Fotos” World Tour.
Measles cases across Europe and Central Asia fell sharply in 2025 compared to the previous year but health officials have warned that the risk of fresh outbreaks remains unless vaccination gaps are urgently addressed.
A Florida university has become a new hotspot in a widening U.S. measles outbreak, with health officials confirming multiple infections and hospitalisations.
The World Health Organization has added the Nipah virus to its list of the world’s top 10 priority diseases, alongside COVID-19 and the Zika virus, warning that its epidemic potential highlights the global risk posed by fast-spreading outbreaks.
Belgian authorities are examining suspected cases of infants falling ill after consuming recalled Nestle baby formula, amid warnings that confirmed infections may be underestimated due to limited testing requirements.
Two Nipah infections involving health workers in India have triggered heightened screening across Southeast Asia as authorities move to prevent the high fatality virus from spreading beyond the country.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment